These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10098673)

  • 21. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
    Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of substrate specificities of sialidase activity between purified enzymes from influenza virus A (H1N1 and H3N2 subtypes) and B strains and their original viruses.
    Nagai T; Suzuki Y; Yamada H
    Biol Pharm Bull; 1995 Sep; 18(9):1251-4. PubMed ID: 8845816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of influenza A viral neuraminidase candidate inhibitors based on a bicyclo[3.1.0]hexane scaffold.
    Colombo C; Pinto BM; Bernardi A; Bennet AJ
    Org Biomol Chem; 2016 Jul; 14(27):6539-53. PubMed ID: 27305457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
    Wyatt PG; Coomber BA; Evans DN; Jack TI; Fulton HE; Wonacott AJ; Colman P; Varghese J
    Bioorg Med Chem Lett; 2001 Mar; 11(5):669-73. PubMed ID: 11266166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.
    Singh S; Jedrzejas MJ; Air GM; Luo M; Laver WG; Brouillette WJ
    J Med Chem; 1995 Aug; 38(17):3217-25. PubMed ID: 7650674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic studies on the sialidase of three influenza B and three influenza A virus strains.
    Cabezas JA; Milicua M; Bernal CS; Villar E; Perez N; Hannoun C
    Glycoconj J; 1989; 6(2):219-27. PubMed ID: 2535486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.
    Honda T; Masuda T; Yoshida S; Arai M; Kaneko S; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1925-8. PubMed ID: 12113810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
    Aoki FY; Hayden FG
    Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
    [No Abstract]   [Full Text] [Related]  

  • 30. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug screening for influenza neuraminidase inhibitors.
    Liu A; Cao H; Du G
    Sci China C Life Sci; 2005 Feb; 48(1):1-5. PubMed ID: 15844351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus.
    Murakami M; Ikeda K; Achiwa K
    Carbohydr Res; 1996 Jan; 280(1):101-10. PubMed ID: 8581891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors.
    Kinger M; Park YD; Park JH; Hur MG; Jeong HJ; Park SJ; Lee WS; Kim SW; Yang SD
    Arch Pharm Res; 2012 Mar; 35(4):633-8. PubMed ID: 22553055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
    Kaji M
    Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorogenic Probes for Accurate in Situ Imaging of Viral and Mammalian Sialidases.
    Kurebayashi Y; Takahashi T; Miura T; Otsubo T; Minami A; Fujita Y; Sakakibara K; Tanabe M; Iuchi A; Ota R; Ikeda K; Suzuki T
    ACS Chem Biol; 2019 Jun; 14(6):1195-1204. PubMed ID: 31120724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UK government not convinced by claims for flu drug.
    Loder N
    Nature; 1999 Oct; 401(6754):631. PubMed ID: 10537096
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
    Honda T; Yoshida S; Arai M; Masuda T; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1929-32. PubMed ID: 12113811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.